TECHWIRE 30
(CIX: WRAL30)  1,137.45  up arrow+1.25  (0.11 %)  Updated: 08:10 PM EST, Jan 23 2015
(NQ: Apple)  112.98  up arrow+0.58  (0.52 %)  Updated: 08:10 PM EST, Jan 23 2015
(NY: QUINTILES)  60.97  up arrow+0.43  (0.71 %)  Updated: 06:40 PM EST, Jan 23 2015
(OP: BASF SE)  86.15  down arrow-0.57  (-0.66 %)  Updated: 05:20 PM EST, Jan 23 2015
(NQ: BioCryst)  10.99  up arrow+0.29  (2.71 %)  Updated: 08:10 PM EST, Jan 23 2015
(NQ: BioDelivery)  12.71  up arrow+0.1  (0.79 %)  Updated: 08:10 PM EST, Jan 23 2015
(NQ: CEMP)  25.49  down arrow-0.8  (-3.04 %)  Updated: 08:10 PM EST, Jan 23 2015
(NQ: Cisco Systems)  28.21  down arrow-0.29  (-1.02 %)  Updated: 08:10 PM EST, Jan 23 2015
(NQ: Cree)  36.81  up arrow+0.2  (0.55 %)  Updated: 08:10 PM EST, Jan 23 2015
(NQ: DARA)  0.81  up arrow+0.02  (2.53 %)  Updated: 08:10 PM EST, Jan 23 2015
(NY: EMC CORPORATION)  28.70  up arrow+0.16  (0.56 %)  Updated: 06:40 PM EST, Jan 23 2015
(NQ: Extreme Networks)  2.83  down arrow-0.05  (-1.74 %)  Updated: 08:10 PM EST, Jan 23 2015
(NQ: FB)  77.83  up arrow+0.18  (0.23 %)  Updated: 08:10 PM EST, Jan 23 2015
(NY: GLAXOSMITHKLINE)  45.01  up arrow+0.05  (0.11 %)  Updated: 06:40 PM EST, Jan 23 2015
(NQ: GOOG)  539.95  up arrow+5.56  (1.04 %)  Updated: 08:10 PM EST, Jan 23 2015
(NY: IBM)  155.87  up arrow+0.48  (0.31 %)  Updated: 06:40 PM EST, Jan 23 2015
(NY: LH)  117.29  down arrow-1.58  (-1.33 %)  Updated: 06:40 PM EST, Jan 23 2015
(OP: Lenovo Group)  26.93  up arrow+0.32  (1.2 %)  Updated: 05:20 PM EST, Jan 23 2015
(NY: MRK)  62.49  down arrow-0.1  (-0.16 %)  Updated: 06:40 PM EST, Jan 23 2015
(NQ: Microsoft Corp)  47.18  up arrow+0.05  (0.11 %)  Updated: 08:10 PM EST, Jan 23 2015
(NQ: NTAP)  39.48  down arrow-0.18  (-0.45 %)  Updated: 08:10 PM EST, Jan 23 2015
(NY: NOVARTIS AG)  96.87  up arrow+0.03  (0.03 %)  Updated: 06:40 PM EST, Jan 23 2015
(OP: Novozymes A/S)  45.04  down arrow-0.45  (-0.99 %)  Updated: 05:20 PM EST, Jan 23 2015
(NY: PFIZER)  32.45  down arrow-0.36  (-1.1 %)  Updated: 06:40 PM EST, Jan 23 2015
(NQ: Pozen)  7.05  down arrow-0.05  (-0.7 %)  Updated: 08:10 PM EST, Jan 23 2015
(NY: RED HAT)  66.06  up arrow+0.14  (0.21 %)  Updated: 06:40 PM EST, Jan 23 2015
(NQ: BBRY)  10.71  up arrow+0.2  (1.86 %)  Updated: 08:10 PM EST, Jan 23 2015
(NQ: Salix)  125.92  down arrow-0.07  (-0.06 %)  Updated: 08:10 PM EST, Jan 23 2015
(NQ: SQI)  14.78  up arrow+0.4  (2.78 %)  Updated: 08:10 PM EST, Jan 23 2015

Posts tagged “GSK”

6:47 a.m. Friday

First GSK Ebola vaccine doses shipping to Africa for trial

Ebola Drug giant GlaxoSmithKline is shipping the first few hundred doses of its vaccine that is being tested as a treatment for Ebola to Africa for further testing. GSK will soon begin testing the vaccine for efficacy. Currently there is no successful treatment for the deadly disease.

Updated 6:32 a.m. Friday

GSK layoffs in China?; Lenovo-Xiamoi showdown; NC wind energy study; China blocks VPNs; Box prices IPO; Uber woes; Verizon loss

Bulldog In today's Bulldog wrapup: GSK reportedly will lay off 1,000 in China; Lenovo takes on Xiaomi with own cheap smartphone in India; feds seek public input on coastal NC wind energy study; China shutting down virtual private networks; Box prices its IPO; Denmark may ban Uber; and Verizon reports a quarterly loss.

6:14 a.m. Wednesday

Doctors without Borders vs. GSK; Etix founder buys Hopscotch; Facebook hoax crackdown; Netflix surges; Twitter buys ZipDial

Bulldog In today's Bulldog wrapup of life science and technology news: Doctors Without Borders calls on GSK, Pfizer to cut vaccine prices; Etix founder buys Raleigh's Hopscotch Music Festival; Facebook cracks down on hoaxes; Netflix growth surges; and Twitter makes an acquisition to grow in developing nations.

January 12

GSK's Ebola vaccine appears safe, World Health Organization says

Ebola The World Health Organization says the two leading Ebola vaccines - including one from GlaxoSmithKline - appear safe and will soon be tested in healthy volunteers in West Africa

December 16, 2014

Premium Lock #WTWTrends for Tuesday: Jobs, GSK, Broadband and Connected Cars Trending in the Triangle

Trending in the Triangle Trending in the Triangle: Get the pulse of technology in the Triangle with the best in local technology, venture, biotech, and life science news on Tuesday, Dec. 16, 2014 as curated by @WRALTechWire.

Updated December 16, 2014

Premium Lock Despite layoffs at GSK, raise a glass (at least) half full

Veteran journalist Jim Shamp sees upside and downside in the recently announced job cuts at GlaxoSmithKline. After all, he notes, cuts in the past as GSK evolved locally from Burrough Wellcome to Glaxo to Glaxo Wellcome and today have produced a harvest of new companies, new ideas, and products. "Yes, a shakeup like GSK's cutback announcement is shattering," he writes. "But these are smart, talented people who will get back on their feet and contribute greatly to North Carolina's life science future."

GSK Headquarters      GSK Headquarters

December 15, 2014

Premium Lock RTP drug firm launching clinical trial of possible Ebola treatment

Ebola RTP-based BioCryst Pharmaceuticals is launching a clinical trial of a potential treatment for Ebola with funding support from the U.S. government. Durham-based Chimerix and GSK also are involved in the Ebola battle.

Updated December 11, 2014

Premium Lock Backers pledge $390M for Ebola; side effects delay one trial

Ebola Even as backers pledged $390 million for Ebola vaccines, Swiss researchers have suspended the testing of one of the leading Ebola vaccine candidates after some volunteers reported unexpected side effects. It's not the vaccine being tested by GlaxoSmithKline.

Updated December 9, 2014

Premium Lock NC firms help lead Ebola fight but face multiple battles

Several North Carolina firms are at the forefront of developing new treatments for the Ebola virus, but they face challenges in testing and delivering them, executives from Chimerix, Quintiles and GlaxoSmithKline say at a conference in RTP.

GSK's Donna Altenpohl GSK's Donna Altenpohl

Updated December 9, 2014

Premium Lock North Carolina's role in fighting Ebola highlights conference in RTP

Ebola North Carolina's role in fighting the Ebola epidemic striking western Africa and a disease that is a global threat will be discussed Monday at a conference in Research Triangle Park.

Updated December 5, 2014

Premium Lock Ebola NC: Conference to focus on state's role, preparations in fighting outbreak

Ebola Government, health, private sector executives will gather at a conference focusing on the Ebola outbreak and North Carolina's involvement as well as preparations for a possible health crisis here.

Updated December 5, 2014

Premium Lock GSK cuts a 'severe blow' to RTP, says science blogger at forefront of layoff reports

Dr. Derek Lowe, a veteran pharmaceutical scientist and long-time Internet blogger, was among the first to report details of GSK's 20% job force reduction in RTP. Fed information from friends and contacts within the industry, he has written several insightful blogs about what's happening at the drug giant and across the pharmaceutical industry, particularly in R&D. And he tells WRAL TechWire that GSK's cuts are a "severe blow" to the Triangle.

December 4, 2014

Premium Lock #WTWTrends for Thursday: GSK, Orion, 12 Days of Broadband, and #Flu Trending in the Triangle

Trending in the Triangle Trending in the Triangle: Get the pulse of technology in the Triangle with the best in local technology, venture, biotech, and life science news on Thursday, Dec. 4, 2014 as curated by @WRALTechWire.

Updated December 3, 2014

Premium Lock GSK files notice confirming 'approximately 900' layoffs in Triangle

GlaxoSmithKline will lay off hundreds of research and development workers at its Research Triangle Park campus, the company said in an official notice to the state.

GSK's R&D facility in RTP  GSK's R&D facility in RTP

Updated December 3, 2014

Premium Lock Hundreds of GSK workers could end up at new RTP employer

GSK  Up to 450 employees of drug giant GlaxoSmithKline who face being laid off may find employment quickly at Parexel, a life science research firm with an office in RTP. GSK says it has signed a letter of intent to create a GSK-focused group within Parexel.

December 3, 2014

Premium Lock #WTWTrends: GSK jobs, HQRaleigh, startups, innovation grants, and Airbnb Trending in the Triangle

Trending in the Triangle Trending in the Triangle: Get the pulse of technology in the Triangle with the best in local technology, venture, biotech, and life science news on Wednesday, Dec. 3, 2014 as curated by @WRALTechWire.

December 3, 2014

Premium Lock GSK's full statement on layoffs: Cuts are 'strategic'

GSK  In a statement, GlaxoSmithKline explains the cutbacks being made in research and development at Research Triangle Park and other locations. "Our proposed changes to R&D will sharpen the focus in discovery and development and reduce funding in certain areas of the pipeline," the drug giant says.

Updated December 1, 2014

Premium Lock Drug giant GSK reportedly will lay off hundreds in US

GlaxoSmithKline is preparing to lay off hundreds of workers in the U.S., according to various media reports. A company spokesperson in RTP, where the company operates its North American headquarters, confirms that a reorganization is underway but won't comment on specifics.

GSK's R&D facility in RTP  GSK's R&D facility in RTP

Updated December 1, 2014

Premium Lock Lost amid layoff news: GSK's advance toward Ebola vaccine

The Ebola outbreak isn't generating big headlines in the U.S. these days, but forthcoming layoffs at GlaxoSmithKline are a hot topic. Unfortunately for GSK, the job cuts have overshadowed the company's progress in developing the first vaccine for the deadly Ebola.

GSK's Andrew Witty talks strategy GSK's Andrew Witty talks strategy

November 19, 2014

Premium Lock Survey shows corporate progress in embracing LGBT equality

A new survey from the Human Rights Campaign finds that a record number of companies, including seven in North Carolina, received perfect scores in corporate inclusion for lesbian, gay, bisexual and transgender employees. Bank of America, Blue Cross Blue Shield of NC and GlaxoSmithKline are among those receiving a "100" on the Corporate Equality Index.

Survey finds more LGBT equality in corporate America Survey finds more LGBT equality in corporate America

Techwire Inside Partners
The Skinny: A Blog by Rick Smith